ES2155783B1 - Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos. - Google Patents

Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.

Info

Publication number
ES2155783B1
ES2155783B1 ES009901037A ES9901037A ES2155783B1 ES 2155783 B1 ES2155783 B1 ES 2155783B1 ES 009901037 A ES009901037 A ES 009901037A ES 9901037 A ES9901037 A ES 9901037A ES 2155783 B1 ES2155783 B1 ES 2155783B1
Authority
ES
Spain
Prior art keywords
lactobacillus casei
preparation
treatment
fermented milks
new use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009901037A
Other languages
English (en)
Other versions
ES2155783A1 (es
Inventor
Amat Pere Pujol
Eric Postaire
Guardia Jose Antonio Mateos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danone SA Spain
Original Assignee
Danone SA Spain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009901037A priority Critical patent/ES2155783B1/es
Application filed by Danone SA Spain filed Critical Danone SA Spain
Priority to EP00935083A priority patent/EP1178730B1/en
Priority to PCT/EP2000/004593 priority patent/WO2000067583A2/en
Priority to DE60018919T priority patent/DE60018919T2/de
Priority to DK00935083T priority patent/DK1178730T3/da
Priority to MXPA01011336A priority patent/MXPA01011336A/es
Priority to AU50695/00A priority patent/AU5069500A/en
Priority to ES00935083T priority patent/ES2238285T3/es
Priority to PT00935083T priority patent/PT1178730E/pt
Priority to AT00935083T priority patent/ATE291353T1/de
Publication of ES2155783A1 publication Critical patent/ES2155783A1/es
Application granted granted Critical
Publication of ES2155783B1 publication Critical patent/ES2155783B1/es
Priority to ES200300009A priority patent/ES2209660B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)

Abstract

Nueva utilización de Lactobacillus casei para la preparación de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos. Utilización de Lactobacillus casei para la preparación de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos de forma transitoria en individuos sometidos a estrés fisiológico con un contenido de Lactobacillus casei superior a 1 x 10{sup,5} ufc por mililitro.
ES009901037A 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos. Expired - Fee Related ES2155783B1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ES009901037A ES2155783B1 (es) 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
PT00935083T PT1178730E (pt) 1999-05-07 2000-05-05 Utilizacao de bacterias do acido lactico na preparacao de leites fermemntados para o tratamento de niveis de imunidade deprimidos
DE60018919T DE60018919T2 (de) 1999-05-07 2000-05-05 Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
DK00935083T DK1178730T3 (da) 1999-05-07 2000-05-05 Anvendelse af mælkesyrebakterier til fremstilling af fermenterede mælkeprodukter til behandling af svækkede immunitetsniveauer
MXPA01011336A MXPA01011336A (es) 1999-05-07 2000-05-05 Uso de bacterias de acido lactico en la preparacion de leches fermentadas para el tratamiento de los niveles deprimidos de inmunidad.
AU50695/00A AU5069500A (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
EP00935083A EP1178730B1 (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
PCT/EP2000/004593 WO2000067583A2 (en) 1999-05-07 2000-05-05 Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
AT00935083T ATE291353T1 (de) 1999-05-07 2000-05-05 Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
ES00935083T ES2238285T3 (es) 1999-05-07 2000-05-05 Uso de bacterias acidolacticas en la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios reducidos.
ES200300009A ES2209660B1 (es) 1999-05-07 2002-12-12 Mejoras en el objeto de la patente principal n.9901037 por: "nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901037A ES2155783B1 (es) 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.

Publications (2)

Publication Number Publication Date
ES2155783A1 ES2155783A1 (es) 2001-05-16
ES2155783B1 true ES2155783B1 (es) 2002-05-16

Family

ID=8308411

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009901037A Expired - Fee Related ES2155783B1 (es) 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
ES200300009A Expired - Fee Related ES2209660B1 (es) 1999-05-07 2002-12-12 Mejoras en el objeto de la patente principal n.9901037 por: "nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES200300009A Expired - Fee Related ES2209660B1 (es) 1999-05-07 2002-12-12 Mejoras en el objeto de la patente principal n.9901037 por: "nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos".

Country Status (1)

Country Link
ES (2) ES2155783B1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5113798A (en) * 1996-11-29 1998-06-22 Bio K & International Inc. Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof
CN1150314C (zh) * 1997-08-21 2004-05-19 纽西兰乳品局 增强免疫的乳酸菌

Also Published As

Publication number Publication date
ES2155783A1 (es) 2001-05-16
ES2209660B1 (es) 2005-04-01
ES2209660A1 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
CA2271930A1 (en) Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
BR9811332A (pt) Bactérias de ácido lático intensificadoras de imunidade
GB0124580D0 (en) New composition
ATE426014T1 (de) Probiotisches bakterium: lactobacillus fermentum
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
NZ502610A (en) Use of lactobacillus for reduction of the fibrinogen level in blood
DE69831578D1 (de) Lactobacillus casei rhamnosus-haltige pharmazeutische formulierung
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
WO2003047524A3 (en) Methods and compositions for modulating the immune system and uses thereof
WO2000071138A3 (en) Oral administration of lactobacillus for the maintenance of health in women
GB2333453A (en) Colostrinin and uses thereof
SE9501719D0 (sv) Pharmaceutical composition
DK1251860T3 (da) Somnogen aktivitet af ikke-patogene mælkesyrebakterier
WO2003053474A3 (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut
ES2155783B1 (es) Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
WO2004001020A3 (en) Methods and means to promote gut absorption
WO2000067583A3 (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
RU2001135344A (ru) Штамм бактерий Lactobacillus rhamnosus 12L для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
CA2304899A1 (en) New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease
曹辉 et al. The effect of health education on survival quality of rehabilitation period in patients with stroke
RU2001135347A (ru) Штамм бактерий Lactobacillus acidophilus 27L для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
BG108620U (en) Lactic acid product
ES2155782A1 (es) Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
MD20010076A (ro) Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010516

Kind code of ref document: A1

Effective date: 20010516

FD2A Announcement of lapse in spain

Effective date: 20190520

FD2A Announcement of lapse in spain

Effective date: 20190603